DEF 14AThe Ballot
Oruka Therapeutics, Inc. files DEF 14A
Filed Nov 3, 2022 · 3y ago · Accession 0001564590-22-036613
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Oruka Therapeutics, Inc.
- Ticker
- ORKA
- CIK
- 907654
- Form type
- DEF 14A
- Filing date
- Nov 3, 2022
- Report date
- Dec 15, 2022
- Document
- abio-def14a_20221215.htm
- Size
- 2.5 MB